Aspen’s Interim Results for the six months ended 31 December 2020 and Results presentation ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) (“Aspen Holdings”) Registration number: 1985/002935/06 Share code: APN ISIN: ZAE000066692 LEI: 635400ZYSN1IRD5QWQ94 (“Aspen” or “the Company”) ASPEN’S INTERIM RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2020 AND RESULTS PRESENTATION Shareholders are advised that Aspen intends releasing its results for the six months ended 31 December 2020 on SENS, after the market closes on Thursday, 11 March 2021. A presentation to members of the investment community will be held virtually at the J.P. Morgan South Africa Healthcare Forum on 12 March 2021 at 08:30 SAST. All interested stakeholders are invited to watch the live webcast which can be accessed using the following link: https://www.corpcam.com/Aspen12032021 The slides accompanying the presentation will be available on the Aspen website, in the Investor Information section at https://www.aspenpharma.com/investor-information/ shortly before the commencement of the presentation on 12 March 2021. A playback of the webcast will be made available on Aspen’s website approximately 2 hours after the presentation. Durban 01 March 2021 Sponsor: Investec Bank Limited Date: 01-03-2021 01:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.